Comparative application of antibody and gene array for expression profiling in human squamous cell lung carcinoma

被引:122
作者
Bartling, B
Hofmann, HS
Boettger, T
Hansen, G
Burdach, S
Silber, RE
Simm, A
机构
[1] Univ Halle Wittenberg, Dept Cardiothorac Surg, Halle Saale, Germany
[2] Univ Halle Wittenberg, Ctr Med Basic Res, Halle Saale, Germany
[3] Univ Halle Wittenberg, Dept Paediat, Div Pneumol & Allergol, Halle Saale, Germany
[4] Tech Univ Munich, Dept Paediat, D-8000 Munich, Germany
[5] Tech Univ Munich, Ctr Comprehens Canc, D-8000 Munich, Germany
关键词
antibody microarray; gene microarray; lung cancer; HDAC3;
D O I
10.1016/j.lungcan.2005.02.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Expression profiting by gene microarray techniques have been developed to predict malignant tissue but there are no experiences with the application of antibody arrays to identify malignancy-related proteins. Because altered protein patterns might also better interpret biological processes, we applied tumour samples from 12 patients with squamous cell lung carcinoma and individual lung tissue controls to antibody arrays spotted with 378 distinct monoclonal antibodies. Array analysis defined 20 proteins with higher and nine with lower abundance in lung tumours. Comparison with gene microarray data revealed that 31% of the differentially regulated proteins correlate with altered mRNA expression in squamous cell lung carcinomas, including PEX1, MKK7 and HDAC3 for up-regulated proteins. The histone deacetylase (HDAC) 3 was investigated in detail by immunoblot analysis showing that HDAC3 is indeed elevated in 92% of tumours (n=22/24; P<0.001). Thus, antibody microarrays can be useful for detection of some target proteins related to Lung cancer. (C) 2005 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:145 / 154
页数:10
相关论文
共 21 条
[1]
GenBank [J].
Benson, DA ;
Karsch-Mizrachi, I ;
Lipman, DJ ;
Ostell, J ;
Rapp, BA ;
Wheeler, DL .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :15-18
[2]
Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses [J].
Bhattacharjee, A ;
Richards, WG ;
Staunton, J ;
Li, C ;
Monti, S ;
Vasa, P ;
Ladd, C ;
Beheshti, J ;
Bueno, R ;
Gillette, M ;
Loda, M ;
Weber, G ;
Mark, EJ ;
Lander, ES ;
Wong, W ;
Johnson, BE ;
Golub, TR ;
Sugarbaker, DJ ;
Meyerson, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (24) :13790-13795
[3]
Prognostic factors in non-small cell lung cancer - A decade of progress [J].
Brundage, MD ;
Davies, D ;
Mackillop, WJ .
CHEST, 2002, 122 (03) :1037-1057
[4]
Expression profile of histone deacetylase 1 in gastric cancer tissues [J].
Choi, JH ;
Kwon, HJ ;
Yoon, BI ;
Kim, JH ;
Han, SU ;
Joo, HJ ;
Kim, DY .
JAPANESE JOURNAL OF CANCER RESEARCH, 2001, 92 (12) :1300-1304
[5]
Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring [J].
Golub, TR ;
Slonim, DK ;
Tamayo, P ;
Huard, C ;
Gaasenbeek, M ;
Mesirov, JP ;
Coller, H ;
Loh, ML ;
Downing, JR ;
Caligiuri, MA ;
Bloomfield, CD ;
Lander, ES .
SCIENCE, 1999, 286 (5439) :531-537
[6]
The human histone deacetylase family [J].
Gray, SG ;
Ekström, TJ .
EXPERIMENTAL CELL RESEARCH, 2001, 262 (02) :75-83
[7]
Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36
[8]
The hallmarks of cancer [J].
Hanahan, D ;
Weinberg, RA .
CELL, 2000, 100 (01) :57-70
[9]
Discrimination of human lung neoplasm from normal lung by two target genes [J].
Hofmann, HS ;
Hansen, G ;
Burdach, S ;
Bartling, B ;
Silber, RE ;
Simm, A .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (05) :516-519
[10]
Clinical relevance of molecular markers in lung cancer [J].
Iyengar, P ;
Tsao, MS .
SURGICAL ONCOLOGY-OXFORD, 2002, 11 (04) :167-179